Favorable and Durable Response to Pazopanib in Metastatic Refractory Paraganglioma

J Oncol Pract. 2017 Dec;13(12):840-842. doi: 10.1200/JOP.2017.024984. Epub 2017 Aug 29.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Biopsy
  • Humans
  • Indazoles
  • Male
  • Middle Aged
  • Paraganglioma / diagnostic imaging
  • Paraganglioma / drug therapy*
  • Paraganglioma / pathology
  • Pyrimidines / therapeutic use*
  • Retroperitoneal Neoplasms / diagnostic imaging
  • Retroperitoneal Neoplasms / drug therapy*
  • Retroperitoneal Neoplasms / pathology
  • Sulfonamides / therapeutic use*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib